1-2 of 2
central nervous system prophylaxis
Close
Sort by
Journal Articles

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery

Clinical Trials & Observations
Matthew R. Wilson, Toby A. Eyre, Nicolas Martinez-Calle, Matthew Ahearne, Katrina E. Parsons, Gavin Preston, Jahanzaib Khwaja, Jeremy Schofield, Johnathon Elliot, Almurtadha Mula Kh, Nimish Shah, Cheuk-Kie Cheung, Matthew A. Timmins, Thomas Creasey, Kim Linton, Jeffery Smith, Christopher P. Fox, Fiona Miall, Kate Cwynarski, Pamela McKay
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3586–3593.
https://doi.org/10.1182/bloodadvances.2020002421
Published: 2020
Includes: Supplemental data
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data